{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:15:09Z","timestamp":1792034109931,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K01 AG046374"],"award-info":[{"award-number":["K01 AG046374"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG056293"],"award-info":[{"award-number":["R01 AG056293"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG056923"],"award-info":[{"award-number":["R01 AG056923"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG044546"],"award-info":[{"award-number":["R01 AG044546"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AG003991"],"award-info":[{"award-number":["P01 AG003991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG053303"],"award-info":[{"award-number":["RF1 AG053303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NIRG-11-200110"],"award-info":[{"award-number":["NIRG-11-200110"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["BAND-14-338165"],"award-info":[{"award-number":["BAND-14-338165"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in the microtubule-associated protein tau (<jats:italic>MAPT<\/jats:italic>) gene cause autosomal dominant frontotemporal lobar degeneration with tau inclusions (FTLD-tau).<jats:italic>MAPT<\/jats:italic>p.R406W carriers present clinically with progressive memory loss and neuropathologically with neuronal and glial tauopathy. However, the pathogenic events triggered by the expression of the mutant tau protein remain poorly understood. To identify the genes and pathways that are dysregulated in FTLD-tau, we performed transcriptomic analyses in induced pluripotent stem cell (iPSC)\u2013derived neurons carrying<jats:italic>MAPT<\/jats:italic>p.R406W and CRISPR\/Cas9-corrected isogenic controls. We found that the expression of the<jats:italic>MAPT<\/jats:italic>p.R406W mutation was sufficient to create a significantly different transcriptomic profile compared with that of the isogeneic controls and to cause the differential expression of 328 genes. Sixty-one of these genes were also differentially expressed in the same direction between<jats:italic>MAPT<\/jats:italic>p.R406W carriers and pathology-free human control brains. We found that genes differentially expressed in the stem cell models and human brains were enriched for pathways involving gamma-aminobutyric acid (GABA) receptors and pre-synaptic function. The expression of GABA receptor genes, including<jats:italic>GABRB2<\/jats:italic>and<jats:italic>GABRG2<\/jats:italic>, were consistently reduced in iPSC-derived neurons and brains from<jats:italic>MAPT<\/jats:italic>p.R406W carriers. Interestingly, we found that GABA receptor genes, including<jats:italic>GABRB2<\/jats:italic>and<jats:italic>GABRG2<\/jats:italic>, are significantly lower in symptomatic mouse models of tauopathy, as well as in brains with progressive supranuclear palsy. Genome wide association analyses reveal that common variants within<jats:italic>GABRB2<\/jats:italic>are associated with increased risk for frontotemporal dementia (<jats:italic>P<\/jats:italic>\u2009&lt;\u20091\u2009\u00d7\u200910<jats:sup>\u22123<\/jats:sup>). Thus, our systems biology approach, which leverages molecular data from stem cells, animal models, and human brain tissue can reveal novel disease mechanisms. Here, we demonstrate that<jats:italic>MAPT<\/jats:italic>p.R406W is sufficient to induce changes in GABA-mediated signaling and synaptic function, which may contribute to the pathogenesis of FTLD-tau and other primary tauopathies.<\/jats:p>","DOI":"10.1038\/s41398-018-0319-z","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T15:38:00Z","timestamp":1543851480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP"],"prefix":"10.1038","volume":"8","author":[{"given":"Shan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7434-6499","authenticated-orcid":false,"given":"Zeran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umber","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Del Aguila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-7276","authenticated-orcid":false,"given":"John","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Dominantly Inherited Alzheimer Network (DIAN)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"International FTD-Genomics Consortium (IFGC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-5547","authenticated-orcid":false,"given":"Celeste M.","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"319_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns, N. J. et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114, 5\u201322 (2007).","journal-title":"Acta Neuropathol."},{"key":"319_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie, I. R. et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119, 1\u20134 (2010).","journal-title":"Acta Neuropathol."},{"key":"319_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1212\/WNL.53.4.864","volume":"53","author":"M Yasuda","year":"1999","unstructured":"Yasuda, M. et al. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. Neurology 53, 864\u2013868 (1999).","journal-title":"Neurology"},{"key":"319_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nan.12213","volume":"41","author":"B Ghetti","year":"2015","unstructured":"Ghetti, B. et al. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol. Appl. Neurobiol. 41, 24\u201346 (2015).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"319_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awx328","volume":"141","author":"SL Forrest","year":"2018","unstructured":"Forrest, S. L. et al. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 141, 521\u2013534 (2018).","journal-title":"Brain"},{"key":"319_CR6","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/humu.22117","volume":"33","author":"M Cruts","year":"2012","unstructured":"Cruts, M., Theuns, J. & Van Broeckhoven, C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum. Mutat. 33, 1340\u20131344 (2012).","journal-title":"Hum. Mutat."},{"key":"319_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1750-3639.2007.00052.x","volume":"17","author":"J van Swieten","year":"2007","unstructured":"van Swieten, J. & Spillantini, M. G. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain. Pathol. 17, 63\u201373 (2007).","journal-title":"Brain. Pathol."},{"key":"319_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ana.410420406","volume":"42","author":"LA Reed","year":"1997","unstructured":"Reed, L. A. et al. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann. Neurol. 42, 564\u2013572 (1997).","journal-title":"Ann. Neurol."},{"key":"319_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I","volume":"46","author":"JC van Swieten","year":"1999","unstructured":"van Swieten, J. C. et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann. Neurol. 46, 617\u2013626 (1999).","journal-title":"Ann. Neurol."},{"key":"319_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1468-1331.2008.02069.x","volume":"15","author":"SG Lindquist","year":"2008","unstructured":"Lindquist, S. G. et al. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur. J. Neurol. 15, 377\u2013385 (2008).","journal-title":"Eur. J. Neurol."},{"key":"319_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0002-9440(10)63979-X","volume":"158","author":"T Miyasaka","year":"2001","unstructured":"Miyasaka, T. et al. Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation. Am. J. Pathol. 158, 373\u2013379 (2001).","journal-title":"Am. J. Pathol."},{"key":"319_CR12","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1523\/JNEUROSCI.0797-04.2004","volume":"24","author":"B Zhang","year":"2004","unstructured":"Zhang, B. et al. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 24, 4657\u20134667 (2004).","journal-title":"J. Neurosci."},{"key":"319_CR13","doi-asserted-by":"publisher","first-page":"13896","DOI":"10.1073\/pnas.202205599","volume":"99","author":"Y Tatebayashi","year":"2002","unstructured":"Tatebayashi, Y. et al. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc. Natl Acad. Sci. USA 99, 13896\u201313901 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"319_CR14","doi-asserted-by":"publisher","first-page":"11856","DOI":"10.1074\/jbc.M509420200","volume":"281","author":"JM Bunker","year":"2006","unstructured":"Bunker, J. M., Kamath, K., Wilson, L., Jordan, M. A. & Feinstein, S. C. FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells. J. Biol. Chem. 281, 11856\u201311863 (2006).","journal-title":"J. Biol. Chem."},{"key":"319_CR15","doi-asserted-by":"publisher","first-page":"20309","DOI":"10.1074\/jbc.M611876200","volume":"282","author":"H Aoyagi","year":"2007","unstructured":"Aoyagi, H., Hasegawa, M. & Tamaoka, A. Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau. J. Biol. Chem. 282, 20309\u201320318 (2007).","journal-title":"J. Biol. Chem."},{"key":"319_CR16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-4159.2008.05692.x","volume":"107","author":"E Chang","year":"2008","unstructured":"Chang, E., Kim, S., Yin, H., Nagaraja, H. N. & Kuret, J. Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps. J. Neurochem. 107, 1113\u20131123 (2008).","journal-title":"J. Neurochem."},{"key":"319_CR17","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1083\/jcb.131.5.1327","volume":"131","author":"R Brandt","year":"1995","unstructured":"Brandt, R., Leger, J. & Lee, G. Interaction of tau with the neural plasma membrane mediated by tau\u2019s amino-terminal projection domain. J. Cell Biol. 131, 1327\u20131340 (1995).","journal-title":"J. Cell Biol."},{"key":"319_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1083\/jcb.201007161","volume":"192","author":"A Gauthier-Kemper","year":"2011","unstructured":"Gauthier-Kemper, A. et al. The frontotemporal dementia mutation R406W blocks tau\u2019s interaction with the membrane in an annexin A2-dependent manner. J. Cell Biol. 192, 647\u2013661 (2011).","journal-title":"J. Cell Biol."},{"key":"319_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"319_CR20","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1073\/pnas.1103509108","volume":"108","author":"H Ban","year":"2011","unstructured":"Ban, H. et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc. Natl Acad. Sci. USA 108, 14234\u201314239 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"319_CR21","doi-asserted-by":"crossref","unstructured":"Budde, J. et al. Precision genome-editing with CRISPR\/Cas9 in human induced pluripotent stem cells. bioRxiv 187377 (2017).","DOI":"10.1101\/187377"},{"key":"319_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch, C. M. et al. Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS ONE 7, e50976 (2012).","journal-title":"PLoS ONE"},{"key":"319_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0551-4","volume":"10","author":"Z Li","year":"2018","unstructured":"Li, Z. et al. Genetic variants associated with Alzheimer\u2019s disease confer different cerebral cortex cell-type population structure. Genome Med. 10, 43 (2018).","journal-title":"Genome Med."},{"key":"319_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.89","volume":"3","author":"M Allen","year":"2016","unstructured":"Allen, M. et al. Human whole genome genotype and transcriptome data for Alzheimer\u2019s and other neurodegenerative diseases. Sci. Data 3, 160089 (2016).","journal-title":"Sci. Data"},{"issue":"1","key":"319_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"Alexander Dobin","year":"2012","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"319_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"319_CR27","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"319_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"319_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"319_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"319_CR31","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.stemcr.2017.05.012","volume":"8","author":"PL Germain","year":"2017","unstructured":"Germain, P. L. & Testa, G. Taming human genetic variability: transcriptomic meta-analysis guides the experimental design and interpretation of iPSC-based disease modeling. Stem Cell Rep. 8, 1784\u20131796 (2017).","journal-title":"Stem Cell Rep."},{"key":"319_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-114","volume":"9","author":"KI Kim","year":"2008","unstructured":"Kim, K. I. & van de Wiel, M. A. Effects of dependence in high-dimensional multiple testing problems. BMC Bioinforma. 9, 114 (2008).","journal-title":"BMC Bioinforma."},{"key":"319_CR33","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1093\/bioinformatics\/btt351","volume":"29","author":"R Gaujoux","year":"2013","unstructured":"Gaujoux, R. & Seoighe, C. CellMix: a comprehensive toolbox for gene expression deconvolution. Bioinformatics 29, 2211\u20132212 (2013).","journal-title":"Bioinformatics"},{"key":"319_CR34","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.meegid.2011.08.014","volume":"12","author":"R Gaujoux","year":"2012","unstructured":"Gaujoux, R. & Seoighe, C. Semi-supervised Nonnegative Matrix Factorization for gene expression deconvolution: a case study. Infect. Genet. Evol. 12, 913\u2013921 (2012).","journal-title":"Infect. Genet. Evol."},{"key":"319_CR35","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1093\/bioinformatics\/btq562","volume":"26","author":"J Montojo","year":"2010","unstructured":"Montojo, J. et al. GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 26, 2927\u20132928 (2010).","journal-title":"Bioinformatics"},{"issue":"W1","key":"319_CR36","doi-asserted-by":"publisher","first-page":"W130","DOI":"10.1093\/nar\/gkx356","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang, J., Vasaikar, S., Shi, Z., Greer, M. & Zhang, B. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res. 45(W1), W130\u2013W137 (2017).","journal-title":"Nucleic Acids Res."},{"key":"319_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin, M. et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 10, 633\u2013644 (2015).","journal-title":"Cell Rep."},{"key":"319_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature10523","volume":"478","author":"HJ Kang","year":"2011","unstructured":"Kang, H. J. et al. Spatio-temporal transcriptome of the human brain. Nature 478, 483\u2013489 (2011).","journal-title":"Nature"},{"key":"319_CR39","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1474-4422(14)70065-1","volume":"13","author":"R Ferrari","year":"2014","unstructured":"Ferrari, R. et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 13, 686\u2013699 (2014).","journal-title":"Lancet Neurol."},{"issue":"Web Server issu","key":"319_CR40","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkq324","volume":"38","author":"K Zhang","year":"2010","unstructured":"Zhang, K., Cui, S., Chang, S., Zhang, L. & Wang, J. i-GSEA4GWAS: a web server for identification of pathways\/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Res. 38(Web Server issue), W90\u2013W95 (2010).","journal-title":"Nucleic Acids Res."},{"key":"319_CR41","first-page":"171","volume":"8","author":"S Jiang","year":"2016","unstructured":"Jiang, S. et al. A systems view of the differences between APOE epsilon4 carriers and non-carriers in Alzheimer\u2019s disease. Front. Aging Neurosci. 8, 171 (2016).","journal-title":"Front. Aging Neurosci."},{"key":"319_CR42","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1126\/science.aad6469","volume":"359","author":"MJ Gandal","year":"2018","unstructured":"Gandal, M. J. et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359, 693\u2013697 (2018).","journal-title":"Science"},{"key":"319_CR43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature22403","volume":"546","author":"H Kilpinen","year":"2017","unstructured":"Kilpinen, H. et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546, 370\u2013375 (2017).","journal-title":"Nature"},{"key":"319_CR44","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","volume":"97","author":"C Sato","year":"2018","unstructured":"Sato, C. et al. Tau kinetics in neurons and the human central nervous system. Neuron 97, 1284\u20131298 e1287 (2018).","journal-title":"Neuron"},{"key":"319_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/nen.0b013e3180301c06","volume":"66","author":"RF Hevner","year":"2007","unstructured":"Hevner, R. F. Layer-specific markers as probes for neuron type identity in human neocortex and malformations of cortical development. J. Neuropathol. Exp. Neurol. 66, 101\u2013109 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"319_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bbadis.2011.07.014","volume":"1822","author":"JD Rohrer","year":"2012","unstructured":"Rohrer, J. D. Structural brain imaging in frontotemporal dementia. Biochim. Biophys. Acta 1822, 325\u2013332 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"319_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/WCO.0b013e3283168e2d","volume":"21","author":"WW Seeley","year":"2008","unstructured":"Seeley, W. W. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia. Curr. Opin. Neurol. 21, 701\u2013707 (2008).","journal-title":"Curr. Opin. Neurol."},{"key":"319_CR48","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00429-010-0263-z","volume":"214","author":"WW Seeley","year":"2010","unstructured":"Seeley, W. W. Anterior insula degeneration in frontotemporal dementia. Brain Struct. Funct. 214, 465\u2013475 (2010).","journal-title":"Brain Struct. Funct."},{"key":"319_CR49","doi-asserted-by":"publisher","first-page":"7826","DOI":"10.1523\/JNEUROSCI.1866-06.2006","volume":"26","author":"LC Tafoya","year":"2006","unstructured":"Tafoya, L. C. et al. Expression and function of SNAP-25 as a universal SNARE component in GABAergic neurons. J. Neurosci. 26, 7826\u20137838 (2006).","journal-title":"J. Neurosci."},{"issue":"Suppl 2","key":"319_CR50","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/BF03161076","volume":"246","author":"DW Dickson","year":"1999","unstructured":"Dickson, D. W. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J. Neurol. 246(Suppl 2), II6\u2013II15 (1999).","journal-title":"J. Neurol."},{"key":"319_CR51","unstructured":"H\u00f6glinger, G. U. et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet. 43, 699 (2011)."},{"key":"319_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8247","volume":"6","author":"N Kouri","year":"2015","unstructured":"Kouri, N. et al. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat. Commun. 6, 7247 (2015).","journal-title":"Nat. Commun."},{"key":"319_CR53","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-017-1693-y","volume":"133","author":"JS Yokoyama","year":"2017","unstructured":"Yokoyama, J. S. et al. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol. 133, 825\u2013837 (2017).","journal-title":"Acta Neuropathol."},{"key":"319_CR54","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neuroscience.2004.09.042","volume":"130","author":"R Lujan","year":"2005","unstructured":"Lujan, R., Shigemoto, R. & Lopez-Bendito, G. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 130, 567\u2013580 (2005).","journal-title":"Neuroscience"},{"key":"319_CR55","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JAD-2012-121330","volume":"33","author":"C Schwab","year":"2013","unstructured":"Schwab, C., Yu, S., Wong, W., McGeer, E. G. & McGeer, P. L. GAD65, GAD67, and GABAT immunostaining in human brain and apparent GAD65 loss in Alzheimer\u2019s disease. J. Alzheimers Dis. 33, 1073\u20131088 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"319_CR56","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1016\/j.celrep.2017.11.073","volume":"21","author":"A Piccini","year":"2017","unstructured":"Piccini, A. et al. APache Is an AP2-Interacting Protein Involved in Synaptic Vesicle Trafficking and Neuronal Development. Cell Rep. 21, 3596\u20133611 (2017).","journal-title":"Cell Rep."},{"key":"319_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/2051-5960-1-34","volume":"1","author":"J Levenga","year":"2013","unstructured":"Levenga, J. et al. Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments. Acta Neuropathol. Commun. 1, 34 (2013).","journal-title":"Acta Neuropathol. Commun."},{"key":"319_CR58","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.stemcr.2013.08.001","volume":"1","author":"H Fong","year":"2013","unstructured":"Fong, H. et al. Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Rep. 1, 226\u2013234 (2013).","journal-title":"Stem Cell Rep."},{"key":"319_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-016-0096-1","volume":"11","author":"GJ Pir","year":"2016","unstructured":"Pir, G. J., Choudhary, B., Mandelkow, E. & Mandelkow, E. M. Tau mutant A152T, a risk factor for FTD\/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model. Mol. Neurodegener. 11, 33 (2016).","journal-title":"Mol. Neurodegener."},{"key":"319_CR60","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.1074\/jbc.M111.309385","volume":"287","author":"NP Nykanen","year":"2012","unstructured":"Nykanen, N. P., Kysenius, K., Sakha, P., Tammela, P. & Huttunen, H. J. gamma-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation. J. Biol. Chem. 287, 6743\u20136752 (2012).","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"319_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000051214","volume":"10","author":"I Ferrer","year":"1999","unstructured":"Ferrer, I. Neurons and their dendrites in frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 10(Suppl 1), 55\u201360 (1999).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"319_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/WNL.45.1.127","volume":"45","author":"R Levy","year":"1995","unstructured":"Levy, R. et al. Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA. Neurology 45, 127\u2013134 (1995).","journal-title":"Neurology"},{"key":"319_CR63","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1212\/WNL.54.9.1768","volume":"54","author":"NL Foster","year":"2000","unstructured":"Foster, N. L. et al. PET measures of benzodiazepine receptors in progressive supranuclear palsy. Neurology 54, 1768\u20131773 (2000).","journal-title":"Neurology"},{"key":"319_CR64","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awx327","volume":"141","author":"AG Murley","year":"2018","unstructured":"Murley, A. G. & Rowe, J. B. Neurotransmitter deficits from frontotemporal lobar degeneration. Brain 141, 1263\u20131285 (2018).","journal-title":"Brain"},{"key":"319_CR65","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary, D. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546\u20131554 (1998).","journal-title":"Neurology"},{"issue":"Suppl 1","key":"319_CR66","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.wad.0000183086.99691.91","volume":"19","author":"AL Boxer","year":"2005","unstructured":"Boxer, A. L. & Miller, B. L. Clinical features of frontotemporal dementia. Alzheimer Dis. Assoc. Disord. 19(Suppl 1), S3\u2013S6 (2005).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"319_CR67","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.2174\/1381612821666150914121149","volume":"21","author":"M Solas","year":"2015","unstructured":"Solas, M., Puerta, E. & Ramirez, M. J. Treatment options in alzheimer s disease: the GABA story. Curr. Pharm. Des. 21, 4960\u20134971 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"319_CR68","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU Hoglinger","year":"2011","unstructured":"Hoglinger, G. U. et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet. 43, 699\u2013705 (2011).","journal-title":"Nat. Genet."},{"key":"319_CR69","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1508","volume":"37","author":"H Stefansson","year":"2005","unstructured":"Stefansson, H. et al. A common inversion under selection in Europeans. Nat. Genet. 37, 129\u2013137 (2005).","journal-title":"Nat. Genet."},{"key":"319_CR70","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat. Genet. 41, 1308\u20131312 (2009).","journal-title":"Nat. Genet."},{"key":"319_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neurobiolaging.2016.09.006","volume":"49","author":"H Soler","year":"2017","unstructured":"Soler, H. et al. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy. Neurobiol. Aging 49, 40\u201351 (2017).","journal-title":"Neurobiol. Aging"},{"key":"319_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2012.03.011","volume":"47","author":"D Loreth","year":"2012","unstructured":"Loreth, D. et al. Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy. Neurobiol. Dis. 47, 1\u201312 (2012).","journal-title":"Neurobiol. Dis."},{"key":"319_CR73","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell 153, 707\u2013720 (2013).","journal-title":"Cell"},{"key":"319_CR74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","volume":"99","author":"B Readhead","year":"2018","unstructured":"Readhead, B. et al. Multiscale analysis of independent Alzheimer\u2019s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron. 99, 64\u201382.e7 (2018).","journal-title":"Neuron."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0319-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0319-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0319-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T23:46:38Z","timestamp":1720827998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0319-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["319"],"URL":"https:\/\/doi.org\/10.1038\/s41398-018-0319-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,13]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"265"}}